Curr Opin Pediatr. 2026 Mar 31. doi: 10.1097/MOP.0000000000001563. Online ahead of print.
ABSTRACT
PURPOSE OF REVIEW: Premenstrual dysphoric disorder (PMDD) is a condition that impacts the quality of life of those affected. Diagnosis can be difficult and lead to delays in treatment. In this article, we review current evidence for the evaluation and treatment of PMDD relevant to pediatric providers and their patients.
RECENT FINDINGS: Recent research emphasizes the difficulties that patients with PMDD face in presenting to care and receiving appropriate diagnosis and treatment. Some of these challenges appear to be exacerbated among populations with comorbid mental health disorders and/or marginalized identities. While there are longstanding data supporting the use of selective serotonin-reuptake inhibitors and oral contraceptive pills in managing PMDD, emerging research provides insight on disease pathophysiology, mechanisms of action for current treatments, and potential horizons for new management options.
SUMMARY: This article aims to provide practical guidelines for pediatricians to use in the initial evaluation and management of PMDD with special considerations for diverse populations.
PMID:41919970 | DOI:10.1097/MOP.0000000000001563
